Monday, September 15, 2025

Latest

Well Health: Canaccord Reiterates Ratings Following Recent Acquisition

Last week WELL Health Technologies (TSX: WELL) announced their latest acquisition, a majority stake in Silicon Valley-based WISP for US$41 million. Consideration consists of $27.7 million in cash and $6.2 million in shares and a potential $7.4 million earnout based on revenue hurdles.

WISP was founded in 2018, is in 50 states, and has served 200,000 patients since its inception. The firm is a telehealth company specializing in women’s health as they offer, “discrete, timely access to treatments for ailments such as yeast infections, UTI’s, herpes, and other ailments related to sexual health.” WISP currently has a run-rate of $30 million with 100% year over year growth, gross margins of >65%, and has been adjusted EBITDA positive for “the last few quarters.”

WELL Health currently has 13 analysts covering the stock with an average 12-month price target of $11.81, or a 52% upside. 3 analysts have strong buy ratings, 9 have buy ratings and 1 analyst has a hold rating on WELL Health. Paradigm Capital has the street high of $14.25 while the lowest sits at $10.

Canaccord Genuity released a note after the news reiterating their $12 price target and speculative buy rating, saying, “We view the WISP transaction positively as a fast-growing business valued at ~2.1x revenue on upfront consideration that not only extends WELL’s primary care footprint in the US but also brings a discreet women’s health experience translatable to patients in WELL’s other care networks.”

Canaccord says that this deal brings WELL Health to a $440 million revenue run rate, which represents “quick execution” and gives a nod to management, who see potential synergies with WISP’s current expertise to serve female patients in Canada.

Below you can see Canaccord’s updated third quarter, 2021, and 2022 estimates, which factor in an October 31 close for WISP. They add, “we forecast near-term losses for WISP as we expect a high degree of reinvestment to support its organic growth strategy within the WELL portfolio.”


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

New Found Gold: The Strategic Maritime Resources Purchase

Amex Exploration: Revised Perron PEA Has INSANE Economics

Aris Mining: The Multi Billion Dollar Soto Norte PFS

Recommended

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

Related News

CloudMD: Canaccord Raises Price Target To $3.75

Wednesday morning, it was announced that CloudMD Software & Services (TSXV: DOC) is acquiring VisionPros,...

Friday, February 19, 2021, 04:01:00 PM

Ontario Opening Doors to Video Based Telemedicine and Digital Practices

In a news release earlier this month from the Province of Ontario, an announcement slid...

Sunday, November 24, 2019, 09:30:02 AM

Antibe: Canaccord Cuts Price Target From $5.00 To $1.20 After Drug Pivot

In early August, Antibe Therapeutics Inc. (TSX: ATE) announced that they have paused their study...

Monday, October 18, 2021, 11:31:00 AM

BMO Drops Cenovus Energy Price Target To $6.00 From $7.50

This morning BMO lowered its 12-month price target on Cenovus Energy (TSX: CVE) to C$6.00...

Friday, October 30, 2020, 11:22:00 AM

CN Rail: BMO Anticipates Continued Strong Earnings

Canadian National Railway (TSX: CNR) last week released its third-quarter financial and operating results. The...

Thursday, November 3, 2022, 04:38:00 PM